DANBIO: Anti-TNFs Do Not Up Overall Cancer Risk in Arthritis
June 3, 2011|Rheumatology News
Author and Disclosure Information
FROM THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
DANBIO is financially supported by grants from the Danish Rheumatism Association and the Danish Cancer Society. Dr. Hetland has acted as a consultant to Roche, and has received grants and research support on behalf of DANBIO from Abbott, BMS, Centocor, Roche, Schering-Plough, UCB-Nordic, and Wyeth. Dr. Dreyer had no disclosures. Dr. Schett was not involved in the study.
